Study of hsa-miR-30e miRNA as a biomarker in identifying multiple gland disease in sporadic primary hyperparathyroidism: Is it time for individualized molecular-based surgery?
Maria Mizamtsidi(Hellenic Red Cross), Maria Gazouli(National and Kapodistrian University of Athens), Constantinos Nastos(National and Kapodistrian University of Athens), Ioannis Vassiliou(National and Kapodistrian University of Athens), Megan Farenden(National and Kapodistrian University of Athens), Fausto Palazzo(Hammersmith Hospital), Roberto Dina(Imperial College London), Vasilis Constantinides(Hammersmith Hospital)
Cited by 0
Related Papers
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
|Surgery|2011|266
Randomized clinical trial of Ligasure™<i>versus</i> open haemorrhoidectomy
|British journal of surgery|2002|154
Systematic review and meta-analysis of retroperitoneoscopic <i>versus</i> laparoscopic adrenalectomy
|British journal of surgery|2012|147
Germline<i>NF1</i>Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1
|The Journal of Clinical Endocrinology & Metabolism|2007|136
Hereditary hyperparathyroidism—a consensus report of the European Society of Endocrine Surgeons (ESES)
|Langenbeck s Archives of Surgery|2015|134